Kyung Mi Lee

Title: Kyung Mi Lee: Innovator in Natural Killer Cell Expansion

Introduction

Kyung Mi Lee is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of immunology, particularly in the area of natural killer (NK) cell therapy. His innovative methods aim to enhance the efficiency of cancer treatment through the use of NK cells.

Latest Patents

Kyung Mi Lee holds a patent for a method titled "Method for the induction and expansion of natural killer cells derived from peripheral blood mononuclear cells." This invention relates to a technique for inducing and expanding NK cells from peripheral blood mononuclear cells. The method involves co-culturing irradiated Jurkat cells and Epstein-Barr virus transformed lymphocyte continuous line (EBV-LCL) cells in the presence of cytokines. This approach allows for the proliferation of a large quantity of NK cells from a small sample, significantly improving the efficiency and efficacy of cancer prevention and treatment.

Career Highlights

Kyung Mi Lee is associated with Nkmax Co., Ltd., a company focused on advancing immunotherapy solutions. His work has been pivotal in developing cost-effective methods for NK cell expansion, which can be crucial for cancer therapies.

Collaborations

Kyung Mi Lee collaborates with notable colleagues, including Seon Ah Lim and Cassian Yee. Their combined expertise contributes to the ongoing research and development in the field of immunotherapy.

Conclusion

Kyung Mi Lee's innovative work in the induction and expansion of natural killer cells represents a significant advancement in cancer treatment methodologies. His contributions are paving the way for more effective and accessible therapies in the fight against cancer.